Skip to Main Content

Paper Details

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.
Science
709
2015
ALS, Amyotrophic lateral sclerosis, OPTN, SQSTM1, TANK-binding kinase 1, TBK1, amyotrophic lateral sclerosis, neurological disease, optineurin, p62, patients, risk genes, sequestosome
Author NameAffiliation
Elizabeth T CirulliCenter for Applied Genomics and Precision Medicine, Duke University School of Medicine
Brittany N LasseigneHudsonAlpha Institute for Biotechnology
Shawn LevyHudsonAlpha Institute for Biotechnology
Shawn LevyHudsonAlpha Institute for Biotechnology
Braden BooneHudsonAlpha Institute for Biotechnology
Braden BooneHudsonAlpha Institute for Biotechnology
Jack R WimbishHudsonAlpha Institute for Biotechnology
Angela L JonesHudsonAlpha Institute for Biotechnology
Aaron G Day-Williams
Alessandra ChesiStanford University School of Medicine
John Q TrojanowskiPerelman School of Medicine, University of Pennsylvania
Wendy K ChungColumbia University
Wendy K ChungColumbia University
Tom ManiatisColumbia University
Andrew S AllenDuke University School of Medicine
Richard BedlackDuke ALS Clinic and Durham VA Medical Center
J. Wade HarperHarvard Medical School
Aaron D GitlerStanford University School of Medicine
Guy A RouleauMontreal Neurological Institute, McGill University
Guy A RouleauMontreal Neurological Institute, McGill University
Gregory M CooperHudsonAlpha Institute for Biotechnology
Gregory M CooperHudsonAlpha Institute for Biotechnology
Richard M MyersHudsonAlpha Institute for Biotechnology
Richard M MyersHudsonAlpha Institute for Biotechnology
David B GoldsteinInstitute for Genomic Medicine, Columbia University
David B GoldsteinInstitute for Genomic Medicine, Columbia University
  • 1 - 26

Datasets

Release 1.2